No Utility of the Wearable Cardioverter-Defibrillator in Patients With Nonischemic Cardiomyopathy?


The recently published paper by Singh et al. (1) about the experience using the wearable cardioverterdefibrillator (WCD) for patients with newly diagnosed cardiomyopathies has caught our interest, and we believe that some comments on the authors’ results and conclusions are necessary. During a 10-year period, the WCD was prescribed for 639 patients; however… (More)
DOI: 10.1016/j.jacc.2016.02.080


  • Presentations referencing similar topics